Anne Marie Foley

This inventor holds 8 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 6 EPO patents. Top assignees: Ucb Pharma, S.a., Ucbbiopharma Srl, Ucb Biopharma Sprl. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anne Marie Foley. Retrieved from https://idiyas.com/inventor/anne-marie-foley

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 3)

% Patents Active = 75.0

CIPO Patents = 3 (Patent Applications = 5)

EPO Patents = 6 (Patent Applications = 9)

Average Co-Inventor Count = 8.6

ph-index = 3

Forward Citations = 32(Granted Patents)

Company Filing History:

Years Active: 2012-2026

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12662475 - Difluorocyclohexyl derivatives as IL-17 modulators (2026-06-23),

2. 12391688 - Imidazopyridine derivatives as IL-17 modulators (2025-08-19),

3. 11052076 - Spirocyclic indolines as IL-17 modulators (2021-07-06),

4. 9550737 - TNF -α modulating benzimidazoles (2017-01-24),

5. 9309243 - Imidazopyridine derivatives as modulators of TNF activity (2016-04-12),

6. 8710054 - Fused thiazole derivatives as kinase inhibitors (2014-04-29),

7. 8338592 - Fused thiazole derivatives as kinase inhibitors (2012-12-25),

8. 8242116 - Fused thiazole derivatives as kinase inhibitors (2012-08-14),

Title: **Innovative Contributions of Anne Marie Foley in Pharmaceutical Patents**

Introduction

Anne Marie Foley, based in Slough, GB, is an accomplished inventor with a remarkable portfolio of six patents. Her work primarily focuses on developing potent modulators for various human ailments, demonstrating her significant impact on pharmaceutical innovations.

Latest Patents

Among her latest patents are two significant contributions to medical science. The first, titled "Spirocyclic Indolines as IL-17 Modulators," presents a series of substituted spirocyclic 2-oxoindoline derivatives. These derivatives act as potent modulators of human IL-17 activity and hold promise for the treatment and prevention of numerous inflammatory and autoimmune disorders.

The second patent, "TNF-α Modulating Benzimidazoles," comprises benzimidazole derivatives that also function as potent modulators of human TNF-α activity. This innovation is geared towards addressing autoimmune and inflammatory disorders, along with neurological, neurodegenerative, pain-related, cardiovascular, metabolic, ocular, and oncological disorders.

Career Highlights

Anne Marie Foley's career includes positions at notable companies such as UCB Pharma and UCB Biopharma. Her time at these leading pharmaceutical companies provided her with essential experience and a collaborative environment to foster her innovative spirit.

Collaborations

Throughout her career, Anne Marie has worked alongside distinguished professionals like Rikki Peter Alexander and Richard Jeremy Franklin. These collaborations have contributed to her ability to produce groundbreaking inventions and expand her patent portfolio.

Conclusion

Anne Marie Foley's contributions to the field of pharmaceuticals through her patents exemplify the critical role of innovation in addressing complex human health challenges. As she continues to develop her work, her inventions are likely to have a lasting impact on medical treatment methodologies and the overall advancement of healthcare solutions.

Profile summary based on public USPTO records.